Kucera Pharmaceuticals Inc.
Document Actions
Kucera Pharmaceuticals Inc.
Kucera Pharmaceuticals Inc.
Kucera Pharmaceuticals Inc., develops novel prodrug technologies for improved drug delivery in the treatment of cancer and viral infections. Kucera was created from research developed at the Wake Forest University School of Medicine and the University of North Carolina at Chapel Hill. UNC Research Associate Professor Susan Morris-Natschke is part of the company's scientific advisory board.